Your browser doesn't support javascript.
loading
Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer.
Hong, Lianlian; Tang, Xi; Han, Jing; Wang, Jiaqi; Xu, Qianqian; Zhu, Xin.
Affiliation
  • Hong L; Experimental Research Centre, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Science, Hangzhou, China.
  • Tang X; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital, Hangzhou, China.
  • Han J; Biological Sample Bank, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Science, Hangzhou, China.
  • Wang J; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
  • Xu Q; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
  • Zhu X; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital, Hangzhou, China. zhuxin@zjcc.org.cn.
Cancer Cell Int ; 24(1): 6, 2024 Jan 03.
Article in En | MEDLINE | ID: mdl-38172873
ABSTRACT

BACKGROUND:

Gastric cancer at different locations has distinct prognoses and biological behaviors, but the specific mechanism is unclear.

METHODS:

Non-targeted metabolomics was performed to examine the differential metabolite phenotypes that may be associated with the effects of tumor location on the prognosis of gastric cancer. And silencing of the rate-limiting enzyme to evaluate the effect of abnormal changes in metabolic pathway on the functional biological assays of gastric cancer cells HGC-27 and MKN28.

RESULTS:

In a retrospective study of 94 gastric cancer patients, the average survival time of patients with gastric cancer in the middle third of the stomach was significantly lower than that of patients with gastric cancer in other locations (p < 0.05). The middle third location was also found to be an independent risk factor for poor prognosis (HR = 2.723, 95%CI 1.334-5.520), which was closely associated with larger tumors in this location. Non-targeted metabolomic analysis showed that the differential metabolites affected 16 signaling pathways including arginine synthesis, retrograde endocannabinoid signaling, arginine biosynthesis, and alanine and aspartate and glutamate metabolism between gastric cancer and normal tissue, as well as between tumors located in the middle third of the stomach and other locations. Argininosuccinate synthetase 1 (ASS1), the rate-limiting enzyme of the arginine biosynthesis pathway, catalyzes the production of argininosuccinic acid. Here, knockdown of ASS1 significantly inhibited the proliferation, colony formation, and migration/invasion of gastric cancer cells, and promoted apoptosis.

CONCLUSIONS:

Our study suggests that abnormal arginine synthesis may lead to larger tumor size and worse prognosis in gastric cancer located in the middle third position of the stomach. These findings may provide the basis for the stratification and targeted treatment of gastric cancer in different locations.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Cell Int Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Cell Int Year: 2024 Type: Article Affiliation country: China